FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and
The Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV — a milestone that the
Read MoreThe Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV — a milestone that the
Read MorePresident Donald Trump, joined by National Institutes of Health (NIH) Director Jay Bhattacharya, speaks during a press conference in the
Read MoreCheck out the companies making headlines in midday trading: T-Mobile — Shares pulled back 11% after the company’s wireless subscribers
Read MoreSubscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.